These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 23453478)

  • 1. Evaluation of spondylarthritis activity by patients and physicians: ASDAS, BASDAI, PASS, and flares in 200 patients.
    Godfrin-Valnet M; Prati C; Puyraveau M; Toussirot E; Letho-Gyselink H; Wendling D
    Joint Bone Spine; 2013 Jul; 80(4):393-8. PubMed ID: 23453478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discriminant validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis: a cohort study.
    Kilic E; Kilic G; Akgul O; Ozgocmen S
    Rheumatol Int; 2015 Jun; 35(6):981-9. PubMed ID: 25366469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary definitions of 'flare' in axial spondyloarthritis, based on pain, BASDAI and ASDAS-CRP: an ASAS initiative.
    Gossec L; Portier A; Landewé R; Etcheto A; Navarro-Compán V; Kroon F; van der Heijde D; Dougados M
    Ann Rheum Dis; 2016 Jun; 75(6):991-6. PubMed ID: 26847821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender difference in ASAS HI among patients with ankylosing spondylitis.
    Chen HH; Chen YM; Lai KL; Hsieh TY; Hung WT; Lin CT; Tseng CW; Tang KT; Chou YY; Wu YD; Huang CY; Hsieh CW; Huang WN; Chen YH
    PLoS One; 2020; 15(7):e0235678. PubMed ID: 32645080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flare in spondyloarthritis: Thresholds of disease activity variations.
    Godfrin-Valnet M; Puyraveau M; Prati C; Wendling D
    Joint Bone Spine; 2015 May; 82(3):192-5. PubMed ID: 25619155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validity and reliability of the Ankylosing Spondylitis Disease Activity Score with C-reactive protein (ASDAS-CRP) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in patients with axial spondyloarthritis (axSpA) in Singapore.
    Kwan YH; Tan JJ; Phang JK; Fong W; Lim KK; Koh HL; Lui NL; Tan CS; Østbye T; Thumboo J; Leung YY
    Int J Rheum Dis; 2019 Dec; 22(12):2206-2212. PubMed ID: 31721427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of disease activity and functional status questionnaires in spondyloarthritis.
    Quinzanos I; Luong PT; Bobba S; Steuart Richards J; Majithia V; Davis LA; Caplan L
    Clin Exp Rheumatol; 2015; 33(2):146-52. PubMed ID: 25664820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of ASDAS and BASDAI as a measure of disease activity in axial psoriatic arthritis.
    Kılıç G; Kılıç E; Nas K; Karkucak M; Çapkın E; Dağlı AZ; Çevik R; Özgöçmen S
    Clin Rheumatol; 2015 Mar; 34(3):515-21. PubMed ID: 24985042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation and reliability of translation of the ASAS Health Index in a Colombian Spanish-speaking population with spondyloarthritis.
    Bautista-Molano W; Landewé RBM; Kiltz U; Valle-Oñate R; van der Heijde D
    Clin Rheumatol; 2018 Nov; 37(11):3063-3068. PubMed ID: 30259248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Minimum Clinically Important Improvement and Patient-acceptable Symptom State in the BASDAI and BASFI for Patients with Ankylosing Spondylitis.
    Kviatkovsky MJ; Ramiro S; Landewé R; Dougados M; Tubach F; Bellamy N; Hochberg M; Ravaud P; Martin-Mola E; Awada H; Bombardier C; Felson D; Hajjaj-Hassouni N; Logeart I; Matucci-Cerinic M; van de Laar M; van der Heijde D
    J Rheumatol; 2016 Sep; 43(9):1680-6. PubMed ID: 27307522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained low functional impairment in axial spondyloarthritis (axSpA): which are the primary outcomes that should be targeted to achieve this?
    Maksymowych WP; Inman RD; Bessette L; Rahman P; Rampakakis E; Asin-Milan O; Rachich M; Marrache AM; Lehman AJ
    Arthritis Res Ther; 2023 Apr; 25(1):70. PubMed ID: 37118833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Equivalent cut-off values of Bath Ankylosing Spondylitis Disease Activity Index corresponding to Ankylosing Spondylitis Disease Activity Score cut-off values.
    Cui R; Du Y; Tian N; Jiang HL; Tao YL; Dai SM
    Clin Exp Rheumatol; 2023 May; 41(5):1163-1169. PubMed ID: 36226617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construct validity and responsiveness of the simplified version of Ankylosing Spondylitis Disease Activity Score (SASDAS) for the evaluation of disease activity in axial spondyloarthritis.
    Salaffi F; Ciapetti A; Carotti M; Gasparini S; Citera G; Gutierrez M
    Health Qual Life Outcomes; 2014 Aug; 12():129. PubMed ID: 25146299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFα inhibitors.
    Pedersen SJ; Sørensen IJ; Garnero P; Johansen JS; Madsen OR; Tvede N; Hansen MS; Thamsborg G; Andersen LS; Majgaard O; Loft AG; Erlendsson J; Asmussen K; Jurik AG; Møller J; Hasselquist M; Mikkelsen D; Skjødt T; Lambert R; Hansen A; Østergaard M
    Ann Rheum Dis; 2011 Aug; 70(8):1375-81. PubMed ID: 21551511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there any gender-specific difference in the cut-off values of ankylosing spondylitis disease activity score in patients with axial spondyloarthritis?
    Kilic G; Kilic E; Ozgocmen S
    Int J Rheum Dis; 2017 Sep; 20(9):1201-1211. PubMed ID: 27309497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Discriminative Values of the Bath Ankylosing Spondylitis Disease Activity Index, Ankylosing Spondylitis Disease Activity Score, C-Reactive Protein, and Erythrocyte Sedimentation Rate in Spondyloarthritis-Related Axial Arthritis.
    Tsang HHL; Chung HY
    J Clin Rheumatol; 2017 Aug; 23(5):267-272. PubMed ID: 28661926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinimetric properties of the ASAS health index in a cohort of Italian patients with axial spondyloarthritis.
    Di Carlo M; Lato V; Carotti M; Salaffi F
    Health Qual Life Outcomes; 2016 May; 14():78. PubMed ID: 27188166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BASDAI cut-off values corresponding to ASDAS cut-off values.
    Kwon OC; Park MC
    Rheumatology (Oxford); 2022 May; 61(6):2369-2374. PubMed ID: 34558610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the Iranian versions of the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), the Bath Ankylosing Spondylitis Functional Index (BASFI) and the Patient Acceptable Symptom State (PASS) in patients with ankylosing spondylitis.
    Bidad K; Fallahi S; Mahmoudi M; Jamshidi A; Farhadi E; Meysamie A; Nicknam MH
    Rheumatol Int; 2012 Nov; 32(11):3613-8. PubMed ID: 22101612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet to albumin ratio is an independent indicator for disease activity in ankylosing spondylitis.
    Cui R; Wang YL; Tao YL; Tong Q; Chen Z; Dai SM
    Clin Rheumatol; 2023 Feb; 42(2):407-413. PubMed ID: 36414863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.